http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-496258-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af13eb9d1aff0858980e3640747fd872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_739134c26b95ab96eb05212a3f77eaf6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 1937-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1938-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-496258-A
titleOfInvention Manufacture of picryl compounds and conversion products thereof
abstract Picrylamino compounds are prepared by condensing picryl chloride or an alkyl derivative thereof with a compound containing a tertiary cyclic nitrogen atom and an adjacent amino group, e.g. 2-aminopyridine, 2-aminoquinoline, 1 - aminoquinoline, 9 - aminophenanthridine and their homologues. Alkyl derivatives of picryl chloride mentioned are methyl- and dimethyl-picryl chlorides, obtainable from m-cresol and m-5-xylenol respectively. By cautious heating ring closure takes place with formation of dinitro-1 : 3-diazalines, from which 1 : 3-diazalines may be obtained by reduction and elimination of the amino groups formed. The ring closure is preferably effected in presence of a substance such as phenol or dimethylaniline having an affinity for the nitrous acid split off. The products are useful as intermediates for the manufacture of dyes and drugs. According to the examples: (1) picryl chloride is heated in benzene solution with 2 aminopyridine to give N-picryl-2-aminopyridine; when toluene is used as a solvent, ring closure takes place with formation of 1 : 2-pyrido-7 : 9-dinitro-4 : 5-benz-1 : 3-diazaline; (2) the same diazaline product is also obtained by heating the N-picryl-2-aminopyridine in dimethylaniline or in a mixture of nitrobenzene with dimethylaniline or phenol; (3) by heating the diazaline product with an aqueous solution of sodium polysulphide, 1 : 2-pyrido-7 : 9- or 9 : 7-nitroamino-4 : 5-benz-1 : 3-diazaline is produced; when using hydrogen as the reducing agent under an initial pressure of 5 atmospheres and in the presence of platinic oxide, 1 : 2-pyrido-7 : 9-diamino 4 : 5-benz-1 : 3-diazaline is formed, whilst at hydrogen pressures maintained between 8 and 10 atmospheres, tetrahydro-1 : 2-pyrido-7 : 9-diamino-4 : 5-benz-1 : 3-diazaline results; (4) 1 : 2-pyrido-7 : 9- or 9 : 7-nitroamino-4 : 5-benz-1 : 3-diazaline is converted by diazotization and heat treatment with alcohol into 1 : 2-pyrido-7 (or 9)-nitro-4 : 5-benz-1 : 3-diazaline, which may then be reduced catalytically with hydrogen at an initial pressure of 5 atmospheres to 1 : 2-pyrido-7 (or 9)-amino-4 : 5-benz-1 : 3-diazaline; the latter on diazotization and decomposition with alcohol yields 1 : 2-pyrido-4 : 5-benz-1 : 3-diazaline, which is isomeric with a -carboline; (5) picryl chloride is condensed as in (1) with 2-amino-3-methylpyridine to form either the picrylamino compound or 31 - methyl - 1 : 2-pyrido-7 : 9-dinitro-4 : 5-benz-1 : 3-diazaline; the picrylamino compound can be converted into the diazaline by heating in phenol and xylene; catalytic reduction of the diazaline using hydrogen under an initial pressure of 5 atmospheres and in presence of platinic oxide produces the diamine, whose bis-diazonium salt decomposes to 31-methyl-1 : 2-pyrido-4 : 5-benz-1 : 3-diazaline; (6) picryl chloride is condensed with 2-aminoquinoline or 1-aminoisoquinoline in benzene solution to give the picrylamino compounds, which yield the corresponding dinitrodiazalines on heating with phenol in xylene; treatment with hydrogen under a pressure of 31 atmospheres in the presence of platinic oxide gives rise to the respective diaminodiazalines, viz.: 1 : 2-quinolo or isoquinolo-7 : 9-diamino-4 : 5-benz-1 : 3-diazaline; elimination of the amino groups from these diazalines by the diazo reaction results in the formation of 1 : 2-quinolo or isoquinolo-4 : 5-benz-1 : 3-diazaline, the former being isomeric with quinindoline; (7) picryl chloride is condensed with 9-aminophenanthridine in xylene and the picrylamino product heated with dimethylaniline to form the dinitrodiazaline. Specification 461,185 is referred to.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006058064-A3
priorityDate 1937-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID345198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360545
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529444
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422105072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406993350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432278286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7237
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154257284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420129604
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7416
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420253832
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10439
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415830569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24529
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12884914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421837857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474448
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20083113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421360616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID996
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135498
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7948
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419574217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458418731
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11379
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486329

Total number of triples: 57.